On this page you can find relevant researchs on drug-related health topics, including HIV, hepatitis C, drug and overdose prevention, harm reduction and drug treatment. You can also find our Clinical Guidelines.

Causes of hospital admission and mortality among 6683 people who use heroin: A cohort study comparing relative and absolute risks
Mortality in high-risk groups such as people who use illicit drugs is often expressed in relative terms such as standardised ratios. These measures are highest for diseases that are rare in the general population, such as hepatitis C, and may understate the importance of common long-term conditions.
Redressing the Balance: How to Reduce Drug-Related Deaths.
There were 4,359 deaths related to drug poisoning in England and Wales in 2018, the highest number and the highest annual increase (16%) since the time series began in 1993. (ONS 2019)
INPUD Statement: HIV2020
The IAS decision to hold the AIDS Conference in the United States shows a disregard for their own organisational values, which include an explicit focus on human rights and inclusivity, whilst encouraging meaningful engagement of people living with HIV and key populations.
First-of-its-kind guideline sets out best practices for delivering injectable opioid agonist treatment
The first-ever Canadian guidelines for prescribing injectable opioid agonist treatment (iOAT) were released today. The clinical guideline provides optimal strategies for delivering iOAT with prescription heroin and hydromorphone for people with severe opioid use disorder.
Monitoring the elimination of viral hepatitis as a public health threat among people who inject drugs in Europe
This technical report focuses on an elimination barometer for viral hepatitis to help countries assess progress towards eliminating hepatitis C and B among people who inject drugs (PWID).
Frequently asked questions (FAQ): drug overdose deaths in Europe
This provides an update on drug-related deaths in Europe, presenting and analysing the latest data on and trends in drug-induced deaths in the European Union, Norway and Turkey. It draws on contributions from specialists from these countries, as well as on information provided by European countries in the annual reporting exercise to the agency.
Good practice examples of hepatitis C interventions by organisations providing harm reduction services in Europe
To reach the ambitious targets to eliminate hepatitis C, community centres, harm reduction and low threshold services have a crucial role to play in linking potential patients to testing and treatment and – even more so – to TREAT patients on-the-spot.
Hepatitis C interventions by organisations providing harm reduction services in Europe – analysis and examples
The following report has been prepared within the framework of the viral hepatitis-related activities developed by Correlation – European Harm Reduction Network (C-EHRN).
Postincarceration Fatal Overdoses After Implementing Medications for Addiction Treatment in a Statewide Correctional System
As the epidemic of opioid use in the United States continues to shift from prescription opioids to illicit drugs, more people living with opioid use disorder are encountering the criminal justice system.
Remembrance Day Statement 2019
Today is the International Day to remember our loved ones who have died as a result of the so-called war on drugs. They have died as a result of their unnecessary criminalisation; they have died as a result of prohibition. It is criminalisation and prohibition that make drugs so dangerous. It is the society in which we live that shows such callous indifference to the deaths of so many.
Share this on: